[144] FS Bancorp, Inc. SEC Filing
FS Bancorp, Inc. (FSBW) filing reports a proposed sale under Rule 144 of 6,674 common shares by a reporting person through Wells Fargo Clearing Services with an aggregate market value of $266,987.36. The filing lists the securities' total outstanding shares as 7,596,336 and an approximate sale date of 08/21/2025. Acquisition history shows grants and option exercises from 2019 through 2024 totaling the lots being sold, including stock-option cash payments in 2021 and 2024. The filer also disclosed two recent sales in the prior three months: 10,864 shares sold on 08/19/2025 for $436,257.43 and 4,914 shares sold on 08/20/2025 for $197,199.34. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.
- Regulatory compliance: The filer provided a complete Rule 144 notice including broker, lot-level acquisition history, and insider attestation.
- Transparency on provenance: Acquisition dates and transaction types (grants and option exercises) are disclosed, clarifying the source of the shares.
- Insider share sales: The reporting person sold 15,778 shares in the prior three months and proposes an additional 6,674-share sale, indicating ongoing insider disposition.
- Potential market perception: Multiple recent insider sales in a short period could be viewed negatively by some investors, despite being routine disclosures.
Insights
TL;DR: Insider selling reported: modest block relative to shares outstanding, with recent prior sales disclosed.
The filing documents a Rule 144 proposed sale of 6,674 common shares valued at $266,987.36 and reports two recent sales totaling 15,778 shares for approximately $633,456.77 in gross proceeds over two days. Relative to the issuer's reported outstanding shares of 7,596,336, the proposed sale represents approximately 0.09% of the outstanding common shares, which is immaterial on a share-count basis but notable as insider liquidity events. The schedule of acquisition dates shows the shares originate from prior grants and option exercises, with cash consideration recorded for option exercises in 2021 and 2024. From a market-impact perspective this disclosure is routine compliance with Rule 144 but signals insider monetization over a short timeframe.
TL;DR: Filing meets disclosure requirements; signals insider disposition but contains no indication of undisclosed adverse facts.
The notice includes the mandatory attestation that no material nonpublic information is known to the seller and lists the broker, planned sale date, and exact lots being sold. The provenance of the shares is documented (grants and option exercises between 2019 and 2024). This provides transparency about the source and timing of the securities offered for sale. There is no text in the filing indicating any change in governance, control, or material corporate developments beyond the sales themselves.